HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Antonia Cagnetta Selected Research
Antonia Cagnetta Research Topics
Disease
15
Neoplasms (Cancer)
10/2020 - 08/2012
10
Multiple Myeloma
01/2022 - 08/2012
5
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
11/2021 - 10/2011
5
Leukemia
10/2020 - 01/2011
5
Hematologic Neoplasms (Hematological Malignancy)
10/2020 - 06/2009
3
BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
09/2020 - 09/2010
2
Residual Neoplasm
11/2021 - 01/2019
2
Genomic Instability
03/2016 - 01/2015
1
Carcinogenesis
10/2020
1
Anemia
09/2020
1
Paraproteinemias (Monoclonal Gammopathy)
01/2020
1
Lymphoma (Lymphomas)
01/2020
1
B-Cell Lymphoma (Lymphoma, B Cell)
01/2020
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1
Starvation
01/2020
1
Pancreatic Neoplasms (Pancreatic Cancer)
01/2017
1
Ovarian Neoplasms (Ovarian Cancer)
01/2017
1
Waldenstrom Macroglobulinemia (Macroglobulinemia)
12/2016
1
Neoplasm Metastasis (Metastasis)
01/2016
1
B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
09/2015
1
Breast Neoplasms (Breast Cancer)
12/2014
1
Inflammation (Inflammations)
01/2013
1
Immune System Diseases (Immune Disorders)
01/2013
1
Ischemia
01/2013
1
Acute Lung Injury
01/2013
1
Osteolysis
08/2012
1
Bone Resorption
08/2012
1
Wilms Tumor (Wilm's Tumor)
10/2011
Drug/Important Bio-Agent (IBA)
8
NAD (NADH)
IBA
01/2018 - 01/2011
6
Nicotinamide Phosphoribosyltransferase
IBA
01/2017 - 01/2013
4
Biological Products
IBA
01/2020 - 10/2012
4
Enzymes
IBA
01/2017 - 10/2012
3
ibrutinib
IBA
10/2020 - 08/2012
3
Proteins (Proteins, Gene)
FDA Link
10/2020 - 12/2014
3
Cytarabine (Cytosar-U)
FDA Link
Generic
01/2020 - 01/2018
2
Agammaglobulinaemia Tyrosine Kinase
IBA
10/2020 - 08/2012
2
DNA (Deoxyribonucleic Acid)
IBA
01/2018 - 01/2015
2
Histone Deacetylases (Histone Deacetylase)
IBA
03/2016 - 01/2011
2
B-Cell Maturation Antigen
IBA
01/2016 - 05/2014
2
bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amine
IBA
01/2016 - 05/2014
2
N- (4- (1- benzoylpiperidin- 4- yl)butyl)- 3- (pyridin- 3- yl)acrylamide
IBA
09/2015 - 06/2009
2
Vorinostat
FDA Link
01/2013 - 01/2011
2
Histone Deacetylase Inhibitors
IBA
01/2013 - 01/2011
1
venetoclax
IBA
01/2022
1
ARQ531
IBA
10/2020
1
Tyrosine Kinase Inhibitors
IBA
10/2020
1
Phosphotransferases (Kinase)
IBA
10/2020
1
RNA (Ribonucleic Acid)
IBA
10/2020
1
Tyrosine (L-Tyrosine)
FDA Link
10/2020
1
Proteasome Endopeptidase Complex (Proteasome)
IBA
10/2020
1
Erythropoietin
FDA Link
09/2020
1
Imatinib Mesylate (Gleevec)
FDA Link
09/2020
1
Untranslated RNA (Noncoding RNA)
IBA
01/2020
1
Asparaginase (Elspar)
FDA Link
01/2020
1
Rituximab (Mabthera)
FDA Link
01/2020
1
Amino Acids
FDA Link
01/2020
1
Cisplatin (Platino)
FDA Link
Generic
01/2020
1
Oxaliplatin (Eloxatin)
FDA Link
Generic
01/2020
1
carfilzomib
IBA
01/2020
1
Dexamethasone (Maxidex)
FDA Link
Generic
01/2020
1
Idarubicin (4 Demethoxydaunorubicin)
FDA Link
Generic
01/2019
1
fludarabine
IBA
01/2019
1
Daunorubicin (Cerubidine)
FDA Link
Generic
01/2018
1
nicotinate phosphoribosyltransferase
IBA
01/2017
1
Interleukin-10 (Interleukin 10)
IBA
01/2016
1
Ligands
IBA
01/2016
1
B7-H1 Antigen
IBA
01/2016
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2016
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2016
1
Cyclosporine (Ciclosporin)
FDA Link
Generic
09/2015
1
Antineoplastic Agents (Antineoplastics)
IBA
12/2014
1
Monoclonal Antibodies
IBA
05/2014
1
Immunoconjugates (Immunoconjugate)
IBA
05/2014
1
belantamab mafodotin
IBA
05/2014
1
Bortezomib (Velcade)
FDA Link
08/2013
1
Messenger RNA (mRNA)
IBA
02/2013
1
Panobinostat
IBA
01/2013
1
Neutralizing Antibodies
IBA
01/2013
1
Chemotactic Factors
IBA
01/2013
1
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
10/2012
1
Mechanistic Target of Rapamycin Complex 1
IBA
10/2012
1
Macrophage Colony-Stimulating Factor
IBA
08/2012
1
Nucleophosmin
IBA
10/2011
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
10/2011
1
Anthracyclines
IBA
10/2011
1
Sirtuin 1
IBA
01/2011
1
cambinol
IBA
01/2011
1
sirtinol
IBA
01/2011
1
Sirtuins
IBA
01/2011
1
Butyric Acid (Butanoic Acid)
IBA
01/2011
1
Valproic Acid (Depakote)
FDA Link
Generic
01/2011
1
Dasatinib (BMS 354825)
FDA Link
09/2010
Therapy/Procedure
4
Therapeutics
09/2020 - 10/2011
1
Stem Cell Transplantation
11/2021
1
Transplantation
01/2020